Inventor · disambiguated record
Thong Vu
Also filed as: VU THONG · VU THONG H · VU THONG HUY
15 granted patents·1 pending application·51 citations·filing 2000–2017
90Inventor score
Top patents by PatentIndex Score
16 records- 0188US8492556B22,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2012·Granted Jul 23, 2013·11 cites·15 claims
- 0283US8440684B2Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulatorsBEARD RICHARD L·Filed 2012·Granted May 14, 2013·6 cites·13 claims
- 0381US7226951B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2004·Granted Jun 5, 2007·13 cites·4 claims
- 0479US8846760B2Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsALLERGAN INC·Filed 2014·Granted Sep 30, 2014·3 cites·8 claims
- 0578US8193203B2Bicyclic compounds having activity at the CXCR4 receptorBEARD RICHARD L·Filed 2009·Granted Jun 5, 2012·3 cites·15 claims
- 0675US8653299B2Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulatorsVULIGONDA VIDYASAGAR·Filed 2012·Granted Feb 18, 2014·3 cites·10 claims
- 0774US6613917B1Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activityALLERGAN INC·Filed 2000·Granted Sep 2, 2003·6 cites·25 claims
- 0871US7468391B2Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26BALLERGAN INC·Filed 2004·Granted Dec 23, 2008·5 cites·12 claims
- 0968US9604934B2Urea hydantoin derivatives as formyl peptide modulatorsALLERGAN INC·Filed 2015·Granted Mar 28, 2017·1 cites·14 claims
- 1063US9868700B2Carbamoyl hydrazine derivatives as formyl peptide modulatorsALLERGAN INC·Filed 2017·Granted Jan 16, 2018·0 cites·17 claims
- 1157US9663457B2Carbamoyl hydrazine derivatives as formyl peptide modulatorsALLERGAN INC·Filed 2015·Granted May 30, 2017·0 cites·11 claims
- 1256US7638648B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2007·Granted Dec 29, 2009·0 cites·10 claims
- 1352US7026487B2Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activityALLERGAN INC·Filed 2003·Granted Apr 11, 2006·0 cites·17 claims
- 1446US9920013B22,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulatorsALLERGAN INC·Filed 2015·Granted Mar 20, 2018·0 cites·11 claims
- 1539US9090624B2Aromatic bycyclic derivatives as CXCR4 receptor modulatorsVULIGONDA VIDYASAGAR·Filed 2012·Granted Jul 28, 2015·0 cites·6 claims
- 1637US2003166932A1Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activityFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thong Vu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →